- Report
- October 2024
- 198 Pages
From €3147EUR$3,545USD£2,744GBP
€3496EUR$3,939USD£3,048GBP
- Report
- October 2025
- 197 Pages
Global
From €3147EUR$3,545USD£2,744GBP
€3496EUR$3,939USD£3,048GBP
- Report
- October 2025
- 184 Pages
Global
From €3147EUR$3,545USD£2,744GBP
€3496EUR$3,939USD£3,048GBP
- Report
- October 2025
- 194 Pages
Global
From €3147EUR$3,545USD£2,744GBP
€3496EUR$3,939USD£3,048GBP
- Report
- October 2025
- 191 Pages
Global
From €3147EUR$3,545USD£2,744GBP
€3496EUR$3,939USD£3,048GBP
- Report
- October 2025
- 185 Pages
Global
From €3147EUR$3,545USD£2,744GBP
€3496EUR$3,939USD£3,048GBP
- Report
- October 2025
- 186 Pages
Global
From €3147EUR$3,545USD£2,744GBP
€3496EUR$3,939USD£3,048GBP
- Report
- October 2025
- 193 Pages
Global
From €3147EUR$3,545USD£2,744GBP
€3496EUR$3,939USD£3,048GBP
- Report
- October 2025
- 183 Pages
Global
From €3147EUR$3,545USD£2,744GBP
€3496EUR$3,939USD£3,048GBP
- Report
- October 2025
- 186 Pages
Global
From €3147EUR$3,545USD£2,744GBP
€3496EUR$3,939USD£3,048GBP
- Report
- August 2025
- 191 Pages
Global
From €3147EUR$3,545USD£2,744GBP
€3496EUR$3,939USD£3,048GBP
- Report
- August 2025
- 194 Pages
Global
From €3147EUR$3,545USD£2,744GBP
€3496EUR$3,939USD£3,048GBP
- Report
- August 2025
- 184 Pages
Global
From €3147EUR$3,545USD£2,744GBP
€3496EUR$3,939USD£3,048GBP
- Report
- August 2025
- 184 Pages
Global
From €3147EUR$3,545USD£2,744GBP
€3496EUR$3,939USD£3,048GBP
- Report
- August 2025
- 192 Pages
Global
From €3147EUR$3,545USD£2,744GBP
€3496EUR$3,939USD£3,048GBP
- Report
- October 2025
- 286 Pages
Global
From €5193EUR$5,850USD£4,527GBP
- Report
- October 2025
- 369 Pages
Global
From €5193EUR$5,850USD£4,527GBP
- Report
- October 2025
- 395 Pages
Global
From €5193EUR$5,850USD£4,527GBP
- Report
- October 2025
- 461 Pages
Global
From €5193EUR$5,850USD£4,527GBP
- Report
- October 2025
- 290 Pages
Global
From €5193EUR$5,850USD£4,527GBP

The Neurotransmitter market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neurotransmitters are chemicals that are released by neurons to send signals to other cells. These drugs are used to treat a variety of neurological disorders, including depression, anxiety, and schizophrenia. Neurotransmitter drugs work by either increasing or decreasing the amount of neurotransmitters in the brain.
The Neurotransmitter market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Eli Lilly, and Merck. Other companies such as Novartis, AstraZeneca, and Johnson & Johnson also have a presence in the Neurotransmitter market. Show Less Read more